LILRB3 antibody (PE)
Quick Overview for LILRB3 antibody (PE) (ABIN2663606)
Target
See all LILRB3 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Purification
- The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions. The solution is free of unconjugated PE and unconjugated antibody.
-
Isotype
- IgG2a kappa
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Buffer
- Phosphate-buffered solution, pH 7.2, containing 0.09 % sodium azide and 0.2 % (w/v) BSA .
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Protect from prolonged exposure to light. Do not freeze.
-
Storage
- 4 °C
-
Storage Comment
- The antibody solution should be stored undiluted between 2°C and 8°C.
-
-
- LILRB3 (Leukocyte Immunoglobulin-Like Receptor B3 (LILRB3))
-
Alternative Name
- CD85a
-
Background
- CD85 is a group of Ig superfamily tansmembrane glycoproteins called Ig-Like Transcripts (ILTs) or Leukocyte Immunoglobulin-like Receptors (LIRs). CD85a is the 110kD member, known as ILT5, LIR-3, or HL9. ILT5 structurally has four extracellular Ig domains and 4 ITIMs in its cytoplasmic tail that provide inhibitory signals. ILT5 is found on the surface of Monocytes/macrophages, granulocytes, NK cells and T-cell subset. ILT5 provides inhibitory signals through interaction with MHC class I molecules.
Target
-